ICLUCIA THERAPEUTICS
Live / Allowed — Publication / registration review complete (as of 20 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jun 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99863311
- Mark type
- Word mark
- Filed
- 03 Jun 2026
- Published for opposition
- 10 Nov 2026
- Attorney of record
- Nicole Kinsley, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy for the treatment of cancer and rare diseases
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceuticals; Consulting services in the field of pharmaceutical research and development; Providing scientific research information in the field of genetics; Providing medical research information in the field of genetics; Providing scientific research information in the field of pharmaceuticals; Providing medical research information in the field of pharmaceuticals
- Class 045 — Legal and security services: Patent licensing; Licensing of intellectual property in the field of genetics and pharmaceuticals
Owner
- ICLUCIA Therapeutics, Inc., Boston, MA, US
Prosecution history
- 04 Nov 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Oct 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 09 Oct 2026 — EXAMINER'S AMENDMENT ENTERED
- 09 Oct 2026 — EXAMINERS AMENDMENT E-MAILED
- 09 Oct 2026 — EXAMINERS AMENDMENT -WRITTEN
- 08 Oct 2026 — ASSIGNED TO EXAMINER
- 07 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 03 Jun 2026 — NEW APPLICATION ENTERED